MRP 187.37/-STRIP

Composition

Each Film Coated Tablet Contains: Montelukast Sodium IP Eq.to Montelukast 10 mg + Excipients q.s.

Doses

As Directed by Physician

Description

Montelukast is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting beta-agonists provide inadequate clinical control of asthma.

Formulation

Tablet